That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19
Abstract Remdesivir is a nucleoside antiviral recently studied in several randomized trials for treatment of COVID-19. The available observational and prospective data are conflicting, requiring clinicians to critically evaluate and reconcile results to determine patient populations that may optimal...
-д хадгалсан:
| Үндсэн зохиолчид: | , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
Adis, Springer Healthcare
2020-07-01
|
| Цуврал: | Infectious Diseases and Therapy |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://doi.org/10.1007/s40121-020-00318-1 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|